Your session is about to expire
← Back to Search
Neurostimulation
Translingual neurostimulation for Post-Traumatic Stress Disorder
N/A
Waitlist Available
Research Sponsored by HealthTech Connex Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 6
Awards & highlights
Study Summary
This trial will test whether a new treatment, combining transcranial electrical stimulation with cognitive processing therapy, is feasible for people with PTSD.
Eligible Conditions
- Post Traumatic Stress Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to week 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 6
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinician-rated symptom severity as measured by CAPS
Ease of protocol administration
Participant rated symptom severity as measured by the PCL-5
+3 moreSecondary outcome measures
Brief Inventory of Psychosocial Functioning (B-IPF)
Electroencephalography (EEG)
Generalized Anxiety Disorder 7-item (GAD-7)
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TLNSExperimental Treatment1 Intervention
Translingual neurostimulation will be paired with breathing and awareness training prior to CPT sessions
Group II: ControlActive Control1 Intervention
No TLNS
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Translingual neurostimulation
2021
N/A
~10
Find a Location
Who is running the clinical trial?
Centre for Neurology StudiesUNKNOWN
HealthTech Connex Inc.Lead Sponsor
4 Previous Clinical Trials
168 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger